Details

---

Manufacturer
SANOFI WINTHROP INDUSTRIE(FRANCE)
Registraction Number
MAL20102007AZ

Here’s the information about RENVELA (Sevelamer Carbonate) Tablet 800mg:

Content

Active Ingredient: Sevelamer carbonate (800 mg per tablet), a phosphate binder.
Excipients: Includes inactive ingredients such as hypromellose, magnesium stearate, and microcrystalline cellulose.

Indication

Used for the control of serum phosphorus levels in patients with:
Chronic Kidney Disease (CKD) on dialysis.
Helps prevent complications like bone disorders and cardiovascular issues caused by elevated phosphorus levels.

Instruction

Dosage:
The starting dose is typically 0.8 g or 1.6 g taken orally three times daily with meals.
Dosage adjustments are made based on serum phosphorus levels.
Administration:
Swallow the tablet whole with water; do not crush or chew.
Take with meals to maximize phosphate binding.
Precautions:
Avoid use in patients with bowel obstruction or hypersensitivity to sevelamer carbonate.
Monitor for potential side effects such as gastrointestinal discomfort, nausea, or constipation.
Separate administration from other oral medications to prevent interactions.